Niklas Bergvall, Phd Email & Phone Number

Stockholm, Stockholm County, Sweden

Basel, Basel-Town, Switzerland

 Lead patient access and TA Policy for all pre-launch and in-market assets in multibillion neuroscience franchise– core member of Global Franchise LT and Global Patient Access LT Leading teams designing and executing strategies to achieve rapid and broad access at target price to neurology portfolio in US, EU5, Japan and China, with a key focus on.

Basel Area, Switzerland

 Lead market access, health systems evidence, and market shaping for launch of Kesimpta  Architect of bold patient access & pricing strategy for Kesimpta - become first High Efficacy Treatment in MS to have unrestricted and accelerated access in US, EU5 and JP (see access outcomes listed above) and enable first line brand strategy  Successfully shaped.

Cambridge, United Kingdom

 Lead market access, health systems evidence, early market shaping and healthcare systems partnerships for all pre-launch and in-market assets in multibillion respiratory portfolio Member of Global Franchise Leadership team and Global Market Access & Pricing Leadership Team, with 15 direct reports

 Lead market access and health systems evidence for launch of Ocrevus, and member of Ocrevus Lifecycle Team Partnered with Genentech to develop a disruptive pricing strategy that maximized the opportunity of launching under medical benefit and buy-n-bill model, and created significant commercial differentiation and enabled a successful lunch (blockbuster.

 Lead and execute global market access and health systems evidence strategies for full MS portfolio

Global HE&OR program lead for Gilenya and BAF312.

Basel Area, Switzerland

Global HE&OR program lead for Gilenya and BAF312.

National responsibility and accountability for all health economic activities, including price and reimbursement submissions, health economic modeling and HE&OR support to sales and marketing departments. Support function to health economic activities in Norway and Denmark.Major achievements: Reimbursement of Gilenya. Reimbursement of Tobi Podhaler

Responsible for national (price and reimbursement submissions. In addition I provide health economic and pricing support to key account manager, regional sales directors, and other key internal stakeholders. Development of local health economic and pricing tools (budget-impact models, simulation models, etc.). Major achievements:"Scandinavian 2009 Most.

Promotion from Research Analyst.

Completed numerous health economic projects in the area of dementia, including statistical analysis plans for clinical trials, cost-of-illness studies, and cost-effectiveness models.

Advanced Marketing Capabilities Program

Doctor Of Philosophy - Phd, Epidemiology

Msc, Statistics

Exchange Student